0001127602-15-003048.txt : 20150128 0001127602-15-003048.hdr.sgml : 20150128 20150128151046 ACCESSION NUMBER: 0001127602-15-003048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150126 FILED AS OF DATE: 20150128 DATE AS OF CHANGE: 20150128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Lynne CENTRAL INDEX KEY: 0001631667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 15554613 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD. STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-01-26 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001631667 Powell Lynne 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - CCO Common Stock 2015-01-26 4 A 0 10000 0 A 10000 D Emp. Stock Option (Right to Buy) 11.33 2015-01-26 4 A 0 190000 0 A 2015-01-26 2025-01-26 Common Stock 190000 190000 D Initial award of Restricted Stock Units which will vest 100% on the first anniversary of the date of grant. Initial Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. /s/ Lynne Powell 2015-01-28